NEW YORK, Jan. 22, 2018 /PRNewswire/ -- Rowley Law
PLLC is investigating potential claims against Bioverativ Inc.
(NASDAQ: BIVV) and its board of directors for breach of fiduciary
duty concerning the proposed acquisition of the company by Sanofi
SA. Stockholders will receive $105.00
for each share of Bioverativ Inc. that they hold. The transaction
is valued at approximately $11.6
billion and is expected to close within the next three
months.
If you are a stockholder of Bioverativ Inc. and are interested
in obtaining additional information regarding this investigation,
please visit us at:
http://www.rowleylawpllc.com/investigation/bioverativ. You
may also contact Shane Rowley, Esq.
at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at
info@rowleylawpllc.com, or by telephone at 914-400-1920 or
844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class
actions and derivative lawsuits in complex corporate litigation.
For more information about the firm and its attorneys, please visit
http://www.rowleylawpllc.com.
Attorney Advertising. Prior results do not guarantee a similar
outcome.
View original
content:http://www.prnewswire.com/news-releases/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-bioverativ-inc-300585978.html
SOURCE Rowley Law PLLC